(5-Oxopyrrolidin-3-yl)methyl 4-methylbenzenesulfonate

Catalog No. :
ACAFLV692
CAS No. :
1005474-47-4
Molecular Formula :
C12H15NO4S
Molecular Weight :
269.32

IUPAC Name:(5-oxopyrrolidin-3-yl)methyl 4-methylbenzenesulfonate

(5-Oxopyrrolidin-3-yl)methyl 4-methylbenzenesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$94.00Login to see priceInquiryInquiry
100mg98%$160.00Login to see priceInquiryInquiry
250mg98%$286.00Login to see priceInquiryInquiry
1g98%$771.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5-Oxopyrrolidin-3-yl)methyl 4-methylbenzenesulfonate
IUPAC Name(5-oxopyrrolidin-3-yl)methyl 4-methylbenzenesulfonate
MDL No.MFCD24387668
Molecular FormulaC12H15NO4S
Molecular Weight269.32
SMILESO=S(C1=CC=C(C)C=C1)(OCC(C2)CNC2=O)=O
InChI KeyUMKOXRYHLSJJQL-UHFFFAOYSA-N
Synonym(5-oxopyrrolidin-3-yl)methyl 4-methylbenzenesulfonate;2-Pyrrolidinone, 4-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-
CAS No.1005474-47-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACAFLV692 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSVYZ793 route compound structure diagram
    ACSVYZ79364320-89-4 In Stock
  4. Then
  5. ACAFLV692 route product structure diagram
    ACAFLV6921005474-47-4
Inquiry

2. ACAFLV692 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOFNP701 route compound structure diagram
    ACOFNP701476423-84-4 In Stock
  4. Then
  5. ACAFLV692 route product structure diagram
    ACAFLV6921005474-47-4
Inquiry

Comments (0)